Publikationen 2014
Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study Drescher SM, von Wyl V, Yang WL, Böni J, Yerly S, Shah C, Aubert V, Klimkait T, Taffé P, Furrer H, Battegay M, Ambrosioni J, Cavassini M, Bernasconi E, Vernazza PL, Ledergerber B, Günthard HF, Kouyos RD and the Swiss HIV Cohort Study Clin Infect Dis. 2014 Jan;58(2):285-94 [abstract] [full-text/pdf]
Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort study Conen A, Wang Q, Glass TR, Fux CA, Thurnheer MC, Orasch C, Calmy A, Bernasconi E, Vernazza P, Weber R, Bucher HC, Battegay M, Fehr J J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):472-8 [abstract] [full-text/pdf]
The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients Beerenwinkel N, Montazeri H, Schuhmacher H, Knupfer P, von Wyl V, Furrer H, Battegay M, Hirschel B, Cavassini M, Vernazza P, Bernasconi E, Yerly S, Böni J, Klimkait T, Cellerai C, Günthard HFand Swiss HIV Cohort Study PLoS Comput Biol. 2013;9(8):e1003203 [abstract] [full-text/pdf]
The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir Young J, Wang Q, Fux C, Bernasconi E, Furrer H, Vernazza P, Calmy A, Cavassini M, Weber R, Battegay M, Bucher H and the Swiss HIV Cohort Study HIV Med. 2014 Mar 18. [abstract] [full-text/pdf]
Higher Risk of Incident Hepatitis C Virus Coinfection Among Men Who Have Sex With Men, in Whom the HIV Genetic Bottleneck at Transmission Was Wide ouyos RD, Rauch A, Braun DL, Yang WL, Böni J, Yerly S, Klimkait T, Aubert V, Shah C, Kovari H, Calmy A, Cavassini M, Battegay M, Vernazza PL, Bernasconi E, Ledergerber B, Günthard HF HIV Med. 2014 Mar 18. [abstract] [full-text/pdf]
[Antiretroviral therapy] von Braun A, Furrer H, Battegay M, Calmy A, Cavassini M, Vernazza P, Bernasconi E, Weber R, Günthard HF Ther Umsch. 2014 Aug;71(8):461-8 [abstract] [full-text/pdf]
[Prevention of HIV and other sexually transmitted infections (STI)] Stoliaroff-Pépin A, Speck RF, Vernazza P Ther Umsch. 2014 Aug;71(8):461-8 [abstract] [full-text/pdf]
Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV-HCV-coinfected individu-als Rohrbach J, Stickel F, Schmid P, Thormann W, Kovari H, Scherrer A, Günthard HF, Vuichard D, Cavassini M, Ambrosioni J, Bernasconi E, Furrer H, Rauch A and the Swiss HIV Cohort Study Antivir Ther. 2013 Sep 13. [abstract] [full-text/pdf]
Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort Study J Schäfer, J Young, E Bernasconi, B Ledergerber, D Nicca, A Calmy, M Cavassini, H Furrer, M Battegay, HC Bucher and the Swiss HIV Cohort Study HIV Medicine (2014). [abstract] [full-text/pdf]
First documented outbreak of KPC-2-producing Klebsiella pneumoniae in Switzerland: infection control measures and clinical man-agement Lemmenmeier E, Kohler P, Bruderer T, Goldenberger D, Kleger GR, Schlegel M Infection. 2014 Jun;42(3):529-34 [abstract] [full-text/pdf]
Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common back-bone. Wang Q, Young J, Bernasconi E, Vernazza P, Calmy A, Cavassini M, Furrer H, Fehr J, Bucher HC, Battegay M and the Swiss Hiv Cohort Study HIV Clin Trials. 2014 May-Jun15 [abstract] [full-text/pdf]
Geschlechtskrankheiten – ein langer Weg Prof. Dr. Pietro Vernazza Präsident Eidgenössische Kommission für Sexuelle Gesundheit ( EKSG) Praxis 2014; 103 (15): 863 – 863 863 [abstract] [full-text/pdf]
Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study Hasse B, Walker AS, Fehr J, Furrer H, Hoffmann M, Battegay M, Calmy A, Fellay J, Di Benedetto C, Weber R, Ledergerber B and the Swiss HIV Cohort Study Antimicrob Agents Chemother. 2014; 58: 2363-8 [abstract] [full-text/pdf]
Pneumococcal colonisation density: a new marker for disease severity in HIV-infected adults with pneumonia Werner C Albrich, Shabir A Madhi, Peter V Adrian, Nadia van Niekerk, Jean-Noel Telles, N Ebrahim, Melina Messaoudi, Glaucia Paranhos-Baccalà, Sven Giersdorf, Guy Vernet, Beat Mueller, Keith P Klugman pneumonia. BMJ Open 2014;4:e005953 [abstract] [full-text/pdf]
Procalcitonin und Pyurie zur Steuerung der Antibiotikatherapie bei Harnwegsinfektionen Daniel Drozdov, Cornelia Ottiger, Werner Albrich pipette – swiss laboratory medicine www.sulm.ch nr. 5 Oktober 2014 [abstract] [full-text/pdf]
Pulmonary actinomycosis and Hodgkin’s disease: when FDG-PET may be misleading C Weisshaupt, F Hitz, W C Albrich, A Omlin 10.1136/BMJ-2014-206034 [abstract] [full-text/pdf]
Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients. Metzner KJ, Scherrer AU, von Wyl V, Böni J, Yerly S, Klimkait T, Aubert V, Furrer H, Hirsch HH, Vernazza PL, Cavassini M, Calmy A, Bernasconi E, Weber R, Günthard HF and the Swiss HIV Cohort Study AIDS. 2014 Sep 24 28(15) 2231-2239 [abstract] [full-text/pdf]
Generation of a Recombinant Gag Virus-Like-Particle Panel for the Evaluation of p24 Antigen Detection by Diagnostic HIV Tests Beatrice N. Vetter, Vanessa Orlowski, Katrien Fransen, Christoph Niederhauser, Vincent Aubert, Marcel Brandenberger, Diana Ciardo, Gu¨ nter Dollenmaier, Thomas Klimkait, Stephan Regenass,Patrick Schmid, Volkmar Schottstedt, Franziska Suter-Riniker, Sabine Yerly, Cyril Shah, Jürg Böni, Jörg Schüpbach PLoS One. 2014 Oct 24;9(10)e111552 [abstract] [full-text/pdf]
Genomic Load from Sputum Samples and Nasopharyngeal Swabs for Diagnosis of Pneumococcal Pneumonia in HIV-Infected Adults Albrich WC, Madhi SA, Adrian PV, Telles JN, Paranhos-Baccalà G, Klugman KP J Clin Microbiol. 2014 Dec;52(12):4224-9 [abstract] [full-text/pdf]
Gender inequalities in the response to combination antiretroviral therapy over time: the Swiss HIV Cohort Study Rosin C, Elzi L, Thurnheer C, Fehr J, Cavassini M, Calmy A, Schmid P, Bernasconi E, Battegay M HIV Med. 2014 Oct 20 [abstract] [full-text/pdf]
Infektiologie: Schutz vor dem «Captain of the men of death» Albrich WC Schweiz Med Forum 2014 14(51–52):973–975 [abstract] [full-text/pdf]
Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study» Boillat-Blanco N, Darling KE, Schoni-Affolter F, Vuichard D, Rougemont M, Fulchini R, Bernasconi E, Aouri M, Clerc O, Furrer H, Günthard HF, Cavassini M and the Swiss HIV Cohort Study Antivir Ther. 2014 Jun 25. doi: 10.3851/IMP2815 [abstract] [full-text/pdf]
First documented outbreak of KPC-2-producing Klebsiella pneumoniae in Switzerland: infection control measures and clinical management
Lemmenmeier E, Kohler P, Bruderer T, Goldenberger D, Kleger GR, Schlegel M.Infection. 2014 Jun;42(3):529-34. doi[abstract] [Autors copy]
